Track topics on Twitter Track topics that are important to you
How data from FibroGen and Galapagos created $1.4 billion in market value. Plus: Vicarius’ EU path for U.S. biotechs; and why Qiming invested in in-licensing play Antengene.
Original Article: IPF call optionsNEXT ARTICLE
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...